WinstonWınston
Amplifon S.p.A. logo

Amplifon S.p.A.

AMP.MI
40
Medical - Distribution · Healthcare
Price
€11.96
+0.02 (+0.17%)
Market Cap
€2.63B
Exchange
Italian Stock Exchange
Winston Score
40
Winston is serious
Mixed quality — meaningful strengths and weaknesses.
Data as of Aug 9, 2026 · filings through Jun 30, 2026

Amplifon is an Italian company that sells and fits hearing aids to people who have trouble hearing. It runs a global network of retail hearing care clinics where trained specialists test customers' hearing and help them choose and adjust hearing devices. Amplifon is one of the largest hearing care retail networks in the world, operating under its own brand as well as local brands in various countries.

The company makes money primarily by selling hearing aids directly to consumers through its clinics, along with follow-up care and accessories. Amplifon operates in over 25 countries across Europe, the Americas, Asia-Pacific, and the Middle East, giving it broad geographic reach that few competitors can match at scale. Its main growth driver is the aging global population, which steadily increases demand for hearing care, though the business faces pressure from rising competition, including lower-cost online hearing aid sellers and direct-to-consumer devices that bypass traditional clinics.

Winston Score History

Share count broadly stable

0.4% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 227.3M (2021) → 226.4M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
11.2%
Thin — 11.2% gross margin
Operating Margin
11.2%
Modest — 11.2% operating margin
ROCE
3.2%
Weak — 3.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-0.7%
Shrinking sales (-0.7% YoY)
EPS YoY
-48.2%
Earnings shrinking (-48.2% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
284%
Turns 284% of profit into real cash
FCF Margin
4.4%
Thin free cash flow (4.4%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.39
Conservative — low debt load (0.39)
Interest Cover
3.49x
Tight — interest eats into profit (3.5x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
41.1x
Pricey — P/E 41.1

P/E over 35. The market is pricing in heavy, sustained growth.

P/E vs Forward
+28.9
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (41.1 → 12.1)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
2.45%
Moderate income — 2.45% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend Growth
+53.7%
Dividend growing fast (53.7% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial